NZ754781A - Thrombin inhibitors for treatment of stroke and related coagulative disorders - Google Patents

Thrombin inhibitors for treatment of stroke and related coagulative disorders

Info

Publication number
NZ754781A
NZ754781A NZ754781A NZ75478117A NZ754781A NZ 754781 A NZ754781 A NZ 754781A NZ 754781 A NZ754781 A NZ 754781A NZ 75478117 A NZ75478117 A NZ 75478117A NZ 754781 A NZ754781 A NZ 754781A
Authority
NZ
New Zealand
Prior art keywords
stroke
treatment
seq
peptide
thrombin inhibitors
Prior art date
Application number
NZ754781A
Other languages
English (en)
Inventor
Richard J Payne
Shaun Phillip Jackson
Pereira Pedro Jose Barbosa
Original Assignee
Univ Sydney
The Heart Res Institute Limited
Ibmc Inst De Biologia Molecular E Celular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016905231A external-priority patent/AU2016905231A0/en
Application filed by Univ Sydney, The Heart Res Institute Limited, Ibmc Inst De Biologia Molecular E Celular filed Critical Univ Sydney
Publication of NZ754781A publication Critical patent/NZ754781A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
NZ754781A 2016-12-16 2017-12-15 Thrombin inhibitors for treatment of stroke and related coagulative disorders NZ754781A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2016905231A AU2016905231A0 (en) 2016-12-16 Thrombin inhibitors for treatment of stroke and related coagulative disorders
PCT/AU2017/051405 WO2018107247A1 (en) 2016-12-16 2017-12-15 Thrombin inhibitors for treatment of stroke and related coagulative disorders

Publications (1)

Publication Number Publication Date
NZ754781A true NZ754781A (en) 2021-12-24

Family

ID=62557849

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ754781A NZ754781A (en) 2016-12-16 2017-12-15 Thrombin inhibitors for treatment of stroke and related coagulative disorders

Country Status (8)

Country Link
US (1) US11091535B2 (https=)
EP (1) EP3555116A4 (https=)
JP (2) JP2020501561A (https=)
CN (1) CN110139871A (https=)
AU (1) AU2017376839B2 (https=)
CA (1) CA3047159A1 (https=)
NZ (1) NZ754781A (https=)
WO (1) WO2018107247A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110590911B (zh) * 2019-09-30 2021-10-22 华南理工大学 一种含酪氨酸硫酸化修饰的多肽合成方法及其应用
CN114887123B (zh) * 2022-04-18 2023-07-04 南通大学 水蛭素接枝纳米纤维血管支架材料、制备方法与应用
CN119462906A (zh) * 2024-11-11 2025-02-18 武汉元启合生科技有限公司 一种酪氨酸硫酸化的重组水蛭素、制备方法及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4323754C1 (de) 1993-07-15 1994-12-01 Gruenenthal Gmbh Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
US6759384B1 (en) * 1994-04-26 2004-07-06 Aventis Pharmaceuticals Inc. Factor Xa inhibitors
WO2001000667A2 (en) * 1999-06-29 2001-01-04 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-thrombin peptide from anopheles albimanus salivary gland
CA2394803A1 (en) * 1999-11-24 2001-05-31 Sugen, Inc. Novel human protein kinases and protein kinase-like enzymes
EP1425296B1 (de) * 2001-09-10 2011-04-13 Novel Science International GmbH Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung
JP3648548B2 (ja) * 2001-10-15 2005-05-18 国立大学法人三重大学 血液凝固阻害活性を有するハマダラカ由来のＡｓ−１蛋白質
DE10301255A1 (de) 2003-01-15 2004-07-29 Cpi Creative Pharma International Gmbh Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung
JP2008532490A (ja) * 2005-02-15 2008-08-21 アポロ ライフ サイエンシズ リミテッド 分子およびそのキメラ分子
WO2007067983A2 (en) * 2005-12-09 2007-06-14 Wyeth Sulfotyrosine specific antibodies and uses therefor
CN100595208C (zh) * 2006-07-31 2010-03-24 浙江中医药大学 硫酸化丝素蛋白的制备方法及其在抗凝血药物上的应用
GB0711779D0 (en) * 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
GB0907698D0 (en) * 2009-05-05 2009-06-10 Univ Singapore Method of modifying serine protease inhibitors
JP2013540995A (ja) * 2010-08-18 2013-11-07 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． 疾患に対する循環バイオマーカー
WO2014194015A1 (en) * 2013-05-30 2014-12-04 Virginia Commonwealth University Sulfated beta-o4 low molecular weight lignins
WO2014194361A1 (en) * 2013-06-04 2014-12-11 The University Of Sydney Peptide ligation
CN106687482B (zh) * 2014-09-17 2022-01-25 诺和诺德股份有限公司 能够结合组织因子途径抑制剂(1-161)上的两个表位的抗体
JP2023529993A (ja) * 2020-06-19 2023-07-12 ザ・ユニバーシティ・オブ・シドニー 血栓塞栓状態の治療のための改良されたトロンビン阻害剤

Also Published As

Publication number Publication date
WO2018107247A1 (en) 2018-06-21
AU2017376839A1 (en) 2019-07-11
JP2022130527A (ja) 2022-09-06
US11091535B2 (en) 2021-08-17
US20190367583A1 (en) 2019-12-05
EP3555116A4 (en) 2020-07-22
JP2020501561A (ja) 2020-01-23
CA3047159A1 (en) 2018-06-21
EP3555116A1 (en) 2019-10-23
CN110139871A (zh) 2019-08-16
AU2017376839B2 (en) 2021-01-14

Similar Documents

Publication Publication Date Title
EP3936141A3 (en) Anti-senescence compounds and uses thereof
EP4467650A3 (en) Scaffold proteins
NZ781143A (en) Anti-vegf protein compositions and methods for producing the same
EA201791238A1 (ru) Способы и композиции, в которых используются варианты полипептидов klotho
MX2023001877A (es) Meganucleasas dise?adas especificas para secuencias de reconocimiento en el gen pcsk9.
ZA202302340B (en) Compositions and methods for treating celiac sprue disease
AU2015269210A8 (en) Methods of constructing amino terminal immunoglobulin fusion proteins and compositions thereof
EA201792651A1 (ru) Аденовирусные полинуклеотиды и полипептиды
WO2011036443A3 (en) Si protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders
HK1243958A1 (zh) 核酸构建体
HK1248714A1 (zh) Ras蛋白的突变的片段
MX2018000697A (es) Peptidos anti-inflamatorios y usos de los mismos.
PH12017501520B1 (en) Fusarium toxin-cleaving polypeptide variants, additives containing same, use of same, and method for splitting fusarium toxins
EP4374913A3 (en) Novel human serum albumin mutant
NZ724196A (en) Uti fusion proteins
NZ754781A (en) Thrombin inhibitors for treatment of stroke and related coagulative disorders
MX2018014966A (es) Peptidos monolipidados resistentes a proteasas.
NZ736652A (en) Short synthetic peptide for treating diseases and/or conditions related to angiogenesis
PH12021551055A1 (en) Klk5 inhibitory peptide
EA202091007A1 (ru) Способ снижения времени восстановления высушенных распылением белковых составов
MX2017008994A (es) Formulacion de peptidos inhibidores mk2.
PH12018500468A1 (en) Fusion protein
WO2015197194A3 (en) New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
EA202190531A1 (ru) Коллекции пептидов, пептидные агенты и способы их применения
EP3925968A3 (en) Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: IBMC (INSTITUTO DE BIOLOGIA MOLECULAR E CELULA, PT

Effective date: 20210813

Owner name: THE HEART RESEARCH INSTITUTE LIMITED, AU

Effective date: 20210813

Owner name: THE UNIVERSITY OF SYDNEY PARRAMATTA ROADTHE UN, AU

Effective date: 20210813

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 DEC 2023 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20221205

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 DEC 2024 BY DENNEMEYER + CO. SARL

Effective date: 20231204

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 DEC 2025 BY DENNEMEYER ET CO

Effective date: 20241202

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 DEC 2026 BY DENNEMEYER + CO. SARL

Effective date: 20251209